Novartis

Austrian Leadership Programs Begins With the Subject of “Life Science”

The Austrian Leadership Programs (ALPs) will run its 15th edition this year from April 17 to 21. Young leaders from around the world will gather in Vienna to discuss and represent the topic of “Life Science”

April 18, 2023

EU Commissioner Breton and Kurz Discuss Vaccine Production

In a meeting in Vienna, EU Commissioner Thierry Breton, who is responsible for vaccine production, Austria's Chancellor Sebastian Kurz and Minister for Economic Affairs Margarete Schramböck discussed the possibilities of Covid-19 vaccine production in the EU and talked about other issues evolving around the different Coronavirus vaccines.

March 9, 2021

Israel, Denmark and Austria Agree on Covid-19 Cooperation

Israel's Prime Minister Benjamin Netanyahu, Denmark's Prime Minister Mette Frederiksen and Austria's Chancellor Sebastian Kurz agreed on establishing a joint research and development foundation as well as on vaccine production. Chancellor Kurz stressed the importance of global cooperation in the fight against Covid-19.

March 5, 2021

Novartis Opens Production Facility for Innovative Eye Retina Product in Tyrol

The pharmaceutical company Novartis is investing EUR 27.4 million in the Kundl site in Tyrol to produce an active ingredient for a new therapy for wet age-related macular degeneration with 40 employees.

June 20, 2020

Intercell Looking for Private Equity Shareholder

According to Bloomberg, the Austrian pharmaceutical company negotiates with potential investors in order to strengthen the equity base.

September 27, 2011

Intercell Is Looking for Financial Investors

The ailing Austrian biotech company is in urgent need of cash. An acquisition, strategic partnerships and a capital increase are being evaluated.

July 19, 2011
Fast News Search